Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Current
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-sale, Current of $357.75 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2025-08-07
- 2025-06-30: Debt Securities, Available-for-sale, Current $357.75M.
- 2025-03-31: Debt Securities, Available-for-sale, Current $273.93M.
- 2024-12-31: Debt Securities, Available-for-sale, Current $232.92M.
- 2024-09-30: Debt Securities, Available-for-sale, Current $40.80M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2025-06-30 | $357.75M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $273.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $232.92M 10-Q · filed 2025-08-07 |
| 2024-09-30 | $40.80M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $350.84M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $205.25M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $74.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $307.14M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $167.85M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $209.05M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $278.64M 10-K · filed 2024-02-28 |